Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results

被引:1
|
作者
Dhanda, Ashwin [1 ,2 ]
Andrade, Jackie [1 ]
Allende, Hannah [3 ]
Allgar, Victoria [1 ]
Bailey, Matthew [1 ]
Callaghan, Lynne [1 ]
Cocking, Laura [1 ]
Goodwin, Elizabeth [4 ]
Hawton, Annie [4 ]
Hayward, Christopher [4 ]
Hudson, Ben [5 ]
Ingram, Wendy [1 ]
Jeffery, Alison [1 ]
King, Angela [1 ]
Lavers, Victoria [6 ]
Lomax, Joe [1 ]
Mccune, C. Anne [6 ]
Musicha, Crispin [1 ]
Parker, Richard [7 ]
Rollinson, Christopher [3 ]
Wilks, Jonny [1 ]
Creanor, E. Siobhan [4 ]
机构
[1] Univ Plymouth, Fac Hlth, Plymouth, England
[2] Univ Hosp Plymouth NHS Trust, South West Liver Unit, Plymouth, England
[3] Univ Hosp Plymouth NHS Trust, Res Dev & Innovat, Plymouth, England
[4] Univ Exeter, Med Sch, Exeter, England
[5] Royal Devon Univ Hosp Fdn NHS Trust, Exeter, England
[6] Univ Hosp Bristol & Weston NHS Fdn Trust, Dept Liver Med, Bristol, England
[7] Leeds Teaching Hosp NHS Trust, Leeds Liver Unit, Leeds, England
来源
BMJ OPEN GASTROENTEROLOGY | 2024年 / 11卷 / 01期
关键词
HEALTH ECONOMICS; LIVER CIRRHOSIS; PSYCHOTHERAPY; ALCOHOLIC LIVER DISEASE; ABSTINENCE; HEALTH;
D O I
10.1136/bmjgast-2023-001267
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective The healthcare burden of alcohol-related liver disease (ARLD) is increasing. ARLD and alcohol use disorder (AUD) is best managed by reduction or cessation of alcohol use, but effective treatments are lacking. We tested whether people with ARLD and AUD admitted to hospital could be recruited to and retained in a trial of Functional Imagery Training (FIT), a psychological therapy that uses mental imagery to reduce alcohol craving. We conducted a multicentre randomised pilot trial of treatment as usual (TAU) versus FIT+TAU in people admitted to hospital with ARLD and AUD.Design Participants were randomised to TAU (a single session of brief intervention) or FIT+TAU (TAU with one hospital-based FIT session then eight telephone sessions over 6 months). Pilot outcomes included recruitment rate and retention at day 180. Secondary outcomes included fidelity of FIT delivery, alcohol use, and severity of alcohol dependence.Results Fifty-four participants (mean age 49; 63% male) were recruited and randomised, 28 to TAU and 26 to FIT+TAU. The retention rate at day 180 was 43%. FIT was delivered adequately by most alcohol nurses. 50% of intervention participants completed FIT sessions 1 and 2. There were no differences in alcohol use or severity of alcohol dependence between treatment groups at day 180.Conclusion Participants with ARLD and AUD could be recruited to a trial of FIT versus FIT+TAU. However, retention at day 180 was suboptimal. Before conducting a definitive trial of FIT in this patient group, modifications in the intervention and recruitment/retention strategy must be tested.Trial registration number ISRCTN41353774.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol
    Dhanda, Ashwin D.
    Allende, Hannah
    Allgar, Victoria
    Andrade, Jackie
    Bailey, Matthew Peter
    Callaghan, Lynne
    Cocking, Laura
    Goodwin, Elizabeth
    Hawton, Annie
    Hayward, Christopher
    Hudson, Ben
    Jeffery, Alison
    King, Angela
    Lavers, Victoria
    Lomax, Joe
    McCune, C. Anne
    Parker, Richard
    Rollinson, Christopher
    Wilks, Jonny
    Creanor, E. Siobhan
    BMJ OPEN, 2022, 12 (05):
  • [2] Strategies are needed to support people with alcohol use disorder and alcohol-related liver disease to take part in randomised clinical trials: results from the MIRAGE pilot trial of functional imagery training
    Dhanda, Ashwin
    Allgar, Victoria
    Andrade, Jackie
    Callaghan, Lynne
    Hudson, Benjamin
    Ingram, Wendy
    King, Angela
    Lavers, Victoria
    Lomax, Joe
    McCune, Anne
    Musicha, Crispin
    Parker, Richard
    Rollinson, Christopher
    Creanor, Siobhan
    JOURNAL OF HEPATOLOGY, 2023, 78 : S153 - S154
  • [3] Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis
    Wandji, Line Carolle Ntandja
    Ningarhari, Massih
    Lassailly, Guillaume
    Dharancy, Sebastien
    Boleslawski, Emmanuel
    Mathurin, Philippe
    Louvet, Alexandre
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (01) : 127 - 138
  • [4] Alcohol-induced pancreatitis and alcohol-related liver disease: Two different phenotypes of alcohol-related harm or related conditions?
    Bjornsson, Einar Stefan
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (02) : 122 - 123
  • [5] Mechanisms of alcohol-related Liver Damage
    Landmann, Marianne
    Bergheim, Ina
    ERNAHRUNGS UMSCHAU, 2013, 60 (05): : M292 - M295
  • [6] Prognostic models in alcohol-related liver disease and alcohol-related hepatitis
    Musto, Jessica Ann
    Lucey, Michael Ronan
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2023, 67
  • [7] The undertreatment of alcohol-related liver diseases among people with alcohol use disorder
    Scafato, E.
    Caputo, F.
    Patussi, V.
    Balbinot, P.
    Addolorato, G.
    Testino, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 974 - 982
  • [8] Alcohol Use and Alcohol-Related Seizures in Patients With Epilepsy
    Hamerle, Michael
    Ghaeni, Leyli
    Kowski, Alexander
    Weissinger, Florian
    Holtkamp, Martin
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [9] ADOLESCENT PROTECTIVE BEHAVIOR TO REDUCE DRUG AND ALCOHOL USE, ALCOHOL-RELATED HARM AND INTERPERSONAL VIOLENCE
    Buckley, Lisa
    Sheehan, Mary
    Chapman, Rebekah
    JOURNAL OF DRUG EDUCATION, 2009, 39 (03) : 289 - 301
  • [10] Alcohol warning labels to reduce alcohol-related harm: a scoping review protocol
    May, Natalie J.
    Eliott, Jaklin
    Crabb, Shona
    Miller, Emma R.
    Braunack-Mayer, Annette
    JBI EVIDENCE SYNTHESIS, 2020, 18 (01) : 186 - 193